LncRNAs in Non-Small-Cell Lung Cancer
Lung cancer is associated with a high mortality, with around 1.8 million deaths worldwide in 2018. Non-small-cell lung cancer (NSCLC) accounts for around 85% of cases and, despite improvement in the management of NSCLC, most patients are diagnosed at advanced stage and the five-year survival remains...
Main Authors: | Lucy Ginn, Lei Shi, Manuela La Montagna, Michela Garofalo |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-06-01
|
Series: | Non-Coding RNA |
Subjects: | |
Online Access: | https://www.mdpi.com/2311-553X/6/3/25 |
Similar Items
-
The Role of LncRNAs in Translation
by: Didem Karakas, et al.
Published: (2021-02-01) -
Aberrant Expression of Pseudogene-Derived lncRNAs as an Alternative Mechanism of Cancer Gene Regulation in Lung Adenocarcinoma
by: Greg L. Stewart, et al.
Published: (2019-03-01) -
Non-Coding RNAs and Cancer
by: Michela Garofalo, et al.
Published: (2013-08-01) -
lncRNAs in development and disease: from functions to mechanisms
by: M. Joaquina Delás, et al.
Published: (2017-01-01) -
Regulation of temozolomide resistance via lncRNAs: Clinical and biological properties of lncRNAs in gliomas (Review)
by: Du, J., et al.
Published: (2022)